Lilly Provides Update on CEO Dr. John Lechleiter
INDIANAPOLIS, May 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that
Lilly Oncology to Release New Pipeline Data at ASCO 2013
Data from Pipeline Molecules Targeting Key Cancer Pathways to be Presented
INDIANAPOLIS, May 14, 2013
Coming Soon To A Doctor Near You? A Simple Test Can Tell If You’re Likely To Develop Hypertension in The Future
Evidence Grows For The Use of Critical Diagnostics’ Biomarker, ST2, In Primary Disease Prevention
Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA
Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA In the largest drug safety...
CEO Olav Hellebø to leave Clavis Pharma
CEO Olav Hellebø to leave Clavis Pharma Oslo, Norway, 14 May 2013 Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, announces that Olav Hellebø will leave...
Assessing Your Asthma is Key to Taking Control
WILMINGTON, Del., May 13, 2013 /PRNewswire/ -- Approximately 25 million Americans suffer from asthma, which a
In Brazil, Mexico and Argentina, Dual Combination Therapy With Peg-IFN-alpha and Ribavirin Remains the Most Commonly Prescribed Treatment for all Hepatitis C Virus-Infected Patients
However, Recent Changes in Brazil and Argentina are Expected to Drive a Shift in Treatment of HCV Genotype 1 Infections, According to a New Report From Decision Resources
Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone
Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone
MALVERN,...
PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
Warner Chilcott Statement Regarding Market Speculation
Warner Chilcott Statement Regarding Market Speculation DUBLIN, Ireland, May 10, 2013 (GLOBE NEWSWIRE) -- Further to media speculation, the Board of Warner Chilcott plc (Nasdaq:WCRX) confirmed today...
Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc
Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc PARSIPPANY, N.J., May 10, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a global specialty...
DURECT Announces Update on Remoxy®
CUPERTINO, Calif., May 10, 2013 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Pfizer
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
LONDON and SOUTH SAN FRANCISCO, Calif., May 10, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK)
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
INDIANAPOLIS, May 10, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Phase III clinic
Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc.
Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. Class Action Asserts Company Discriminates Against Female Sales Reps NEWARK, N.J., May 9, 2013 -- Sanford...
Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis Ilaris® (canakinumab) is the first interleukin-1 beta...
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients THOUSAND OAKS, Calif. and ZHEJIANG, China, May...
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients
THOUSAND OAKS, Calif. and ZHEJIANG,
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
ABBOTT PARK, Ill., May 9, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced CE Marking (Conformité Européenne) for the ARCHITE
Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc.
Class Action Asserts Company Discriminates Against Female Sales Reps
NEWARK, N.J., May 9, 2013 /PRNe
